REG - Circassia Group Plc AstraZeneca PLC - Holding(s) in Company

AstraZenecaAnnouncement

05/05/2021 18:35

RNS Number : 6943X
  
Circassia Group Plc
  
05 May 2021
  
 

 
TR-1: Standard form for notification of major holdings
 



NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i










1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: 


Circassia Group PLC




1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)




Non-UK issuer








2. Reason for the notification (please mark the appropriate box or boxes with an "X")




An acquisition or disposal of voting rights








An acquisition or disposal of financial instruments








An event changing the breakdown of voting rights








Other (please specify) iii: A change in the total voting rights notified by Circassia Group PLC on 
30 April 2021


X




3. Details of person subject to the notification obligation iv




Name


AstraZeneca PLC




City and country of registered office (if applicable)


Cambridge, England




4. Full name of shareholder(s) (if different from 3.) v




Name


AstraZeneca UK Limited




City and country of registered office (if applicable)


Cambridge, England




5. Date on which the threshold was crossed or reached vi:


30/04/2021




6. Date on which issuer notified (DD/MM/YYYY):


05/05/2021




7. Total positions of person(s) subject to the notification obligation








% of voting rights attached to shares (total of 8. A)


% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)


Total of both in % (8.A + 8.B)


Total number of voting rights held in issuer (8.A + 8.B) vii




Resulting situation on the date on which threshold was crossed or reached


16.997%






16.997%


71,081,217




Position of previous notification (if 
applicable)


17.89%
























 



8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii




A: Voting rights attached to shares




Class/type of

shares
ISIN code (if possible)


Number of voting rights ix


% of voting rights




Direct
(DTR5.1)


Indirect
 (DTR5.2.1)


Direct
(DTR5.1)


Indirect
(DTR5.2.1)




Ordinary shares of 0.08 pence
GB00BJVD3B28






71,081,217






16.997%
















































SUBTOTAL 8. A


71,081,217


16.997%




 
 




B 1: Financial Instruments according to DTR5.3.1R (1) (a)




Type of financial instrument


Expiration

date x


Exercise/

Conversion Period xi


Number of voting rights that may be acquired if the instrument is 
exercised/converted.


% of voting rights














































































SUBTOTAL 8. B 1












 
 




B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)




Type of financial instrument


Expiration

date x


Exercise/

Conversion Period xi


Physical or cash 
Settlement xii


Number of voting rights 


% of voting rights






























































































SUBTOTAL 8.B.2












 
 















 



9. Information in relation to the person subject to the notification obligation (please mark the 
applicable box with an "X")




Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii








Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv


X




Name xv


% of voting rights if it equals or is higher than the notifiable threshold


% of voting rights through financial instruments if it equals or is higher than the notifiable threshold


Total of both if it equals or is higher than the notifiable threshold




AstraZeneca PLC


16.997%






16.997%




AstraZeneca Intermediate Holdings Limited


16.997%






16.997%




AstraZeneca UK Limited 


16.997%






16.997%














































10. In case of proxy voting, please identify:




Name of the proxy holder








The number and % of voting rights held








The date until which the voting rights will be held














11. Additional information xvi
















 



Place of completion


Cambridge, England




Date of completion


05/05/2021



 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
HOLAAMRTMTTMBPB